FridaySep 11, 2026 10:30 am

QualityStocksNewsBreaks – Vertical Data Inc. (OTCQB: VDTA) Enters Definitive Agreement to Acquire 4.5 MW Data Center Site in Sweden 

Vertical Data (OTCQB: VDTA), a vertically integrated AI infrastructure company providing GPU financing, AI hardware, sovereign cloud and edge data center solutions, entered into a definitive purchase agreement through its majority-owned Vertical Data Nordic AB to acquire an existing industrial data center site with 4.5 MW of power capacity in Sollefteå Municipality in Central Sweden. If the transaction proceeds, Vertical Data intends to continue pursuing an application for up to 100 MW of total power capacity to build out an AI data center facility. The company said the project is among several in an active conversion pipeline representing more than 250 MW of global data center opportunities.…

Continue Reading

FridaySep 11, 2026 10:22 am

QualityStocksNewsBreaks – Nanox Imaging Ltd. (NASDAQ: NNOX) Signs Nanox.ARC Distribution Agreement for Costa Rica

Nanox (NASDAQ: NNOX) announced a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. SOLME will oversee marketing, distribution, installation, training and ongoing technical support in Costa Rica, where it is a registered supplier to the Caja Costarricense de Seguro Social (“CCSS”), the country principal purchaser and provider of hospital services. Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration, and Costa Rica represents Nanox third Latin American market this year…

Continue Reading

FridaySep 11, 2026 9:20 am

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Featured in BioMedWire Editorial on Lucid-MS Phase 2 Trial

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) announced its placement in a BioMedWire editorial examining the potential of Lucid-MS to address limitations of existing multiple sclerosis (“MS”) treatments. The editorial highlights Quantum BioPharma’s U.S. Food and Drug Administration (“FDA”) clearance to launch a phase 2 trial of Lucid-MS, a patented, first-in-class candidate designed to protect and potentially rebuild the myelin sheath rather than suppress the immune system. According to the publication, the trial would mark the first time a drug based on this mechanism is tested in people…

Continue Reading

ThursdaySep 10, 2026 1:06 pm

QualityStocksNewsBreaks – AmpliTech Group, Inc. (NASDAQ: AMPG, AMPGZ) Receives $7.3 Million in Follow-On Orders for Asian 5G O-RAN Deployment 

AmpliTech Group (NASDAQ: AMPG, AMPGZ) received approximately $7.3 million in follow-on orders supporting deployments for an Asian mobile network operator (“MNO”) under its previously announced 5G O-RAN radio Letter of Intent (“LOI”) program. The orders follow deployment of AmpliTech O-RAN radios at end-customer 5G sites and represent renewed purchasing activity under the program. The company said the orders, together with recently received follow-on orders supporting its North American MNO program, restore momentum under the LOI program and support its efforts to convert its opportunity pipeline into shipments and revenue. To view the full press release, visit https://ibn.fm/p85ry About AmpliTech Group, Inc. AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGZ)…

Continue Reading

ThursdaySep 10, 2026 1:05 pm

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Bolsters Scientific Leadership Ahead of BiTAC(R) Clinical Development

VERAXA Biotech (NASDAQ: VRXA) recently appointed antibody therapeutics specialist Dr. Christoph Erkel as its chief scientific officer, taking responsibility for advancing the company’s proprietary BiTAC(R) technology and broader oncology pipeline toward clinical development. The company’s lead BiTAC-TCE program uses a conditionally active, dual-targeting approach designed to selectively activate T cells against cancer cells while potentially limiting effects on healthy tissue. Recent scientific advice from Germany’s Paul-Ehrlich-Institute provided additional clarity around the program’s proposed non-clinical development strategy, while preclinical data presented at the AACR Annual Meeting showed selective activity against cells expressing both target molecules. Beyond BiTAC, VERAXA is developing bispecific antibody-drug…

Continue Reading

ThursdaySep 10, 2026 12:37 pm

QualityStocksNewsBreaks – Silver Bow Mining Corp. (NYSE American: SBMT) Receives Bankruptcy Court Approval, Completes Initial Closing for Jefferson County Metallurgical Complex 

Silver Bow Mining (NYSE American: SBMT) announced that the U.S. Bankruptcy Court for the District of Montana approved the sale of specified Montana Tunnels Mining assets comprising the Jefferson County Metallurgical Complex to Silver Bow and its wholly owned subsidiary, Silver Bow Tunnels Corp. The company also completed the initial closing under its previously announced definitive asset purchase agreement after funding approximately $28.58 million into escrow to satisfy specified creditor obligations, including approximately $4.27 million owed to Jefferson County and $20.78 million in specified obligations to the Montana Department of Environmental Quality. The initial closing does not transfer ownership of the Complex to Silver Bow. The company…

Continue Reading

ThursdaySep 10, 2026 12:24 pm

QualityStocksNewsBreaks – Perpetuals.com Ltd. (NASDAQ: PDC) Launches Joint AI Trading Research Group with European Institute of Management 

Perpetuals.com (NASDAQ: PDC) and the European Institute of Management (“EIM”) launched a joint research group pairing more than 20 doctoral researchers with Perpetuals to develop AI-powered trading models combining machine learning and crowd intelligence. The researchers will have access to Perpetuals proprietary trading datasets and live venue data, with work focused on behavioral finance, trader performance classification, market microstructure and model risk. The initiative is expected to run for at least three years, with more than half of the participating researchers currently employed by Perpetuals. To view the full press release, visit https://ibn.fm/xSf7A About Perpetuals Perpetuals.com Ltd (NASDAQ: PDC) is a fintech company developing…

Continue Reading

ThursdaySep 10, 2026 12:17 pm

QualityStocksNewsBreaks – Earth Science Tech Inc.’s (ETST) B2B-B2C Healthcare Platform Powers Continued Revenue Growth

Earth Science Tech (OTC: ETST) is positioning itself as a vertically integrated healthcare company through its subsidiaries RxCompoundStore, Mister Meds, and Peaks Curative, combining compounding pharmacy, telemedicine, clinical support, and fulfillment capabilities. Its B2B and B2C business model allows the company to serve independent clinics while also selling customized medications directly to consumers, creating diversified revenue streams across physical and digital healthcare operations. In FY2026, ETST reported revenue of $35.7 million, up from $33.1 million in FY2025 and $11.95 million in FY2024, while also reporting positive operating cash flow and a stronger balance sheet. The company reduced total liabilities from $3.146…

Continue Reading

ThursdaySep 10, 2026 11:15 am

SS Innovations International Inc. (NASDAQ: SSII) Brings Robotic Cardiac Surgery to Sri Lanka

The company has supported the launch of Sri Lanka’s first robotic cardiac surgery program at Kings Hospital Colombo using the SSi Mantra 3.0 surgical robotic system. The program began with a robotic-assisted LIMA takedown, performed by SS Innovations founder and Chairman Dr. Sudhir Srivastava alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva. Kings Hospital has completed more than 25 robotic procedures in three weeks, according to a recent company video describing the program’s early activity. SS Innovations reported 224 cumulative SSi Mantra installations across 12 countries at the end of the second quarter. The company’s second-quarter revenue reached $13.9 million,…

Continue Reading

ThursdaySep 10, 2026 10:30 am

Wrap Technologies Inc. (NASDAQ: WRAP) Broadens Public Safety Platform as Training, Technology and Response Capabilities Converge

WRAP(R) is expanding beyond individual public safety technologies by integrating training, situational awareness, response capabilities, and continuous learning into a broader platform. Its relationship with WOFT Charities and Florida’s Teacher Safety Training Program demonstrates how WRAP’s training methodology can extend into new professional environments. The company’s Wrap Tactics(TM) learning management system could provide a scalable foundation for certification, recurring training, and broader adoption across education, private security, military, and other markets. Public safety technology is increasingly moving beyond individual products as organizations seek solutions that combine technology with training, situational awareness, real-world scenarios, and continuous professional development. Wrap Technologies (NASDAQ:…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered